Skip to main content
. 2009 Sep 15;101(8):1433–1443. doi: 10.1038/sj.bjc.6605316

Table 1. Clinicopathological correlation of FOXG1 expression in ovarian cancer patients.

    FOXG1 expression (fold)
Characteristics Total ⩽1.5 >1.5 P
All cases 67 33 (49.25%) 34 (50.75%)  
         
Age (y)
 <55 39 16 (41.03%) 23 (58.97%)  
 >55 28 17 (60.71%) 11 (39.29%) 0.112
         
Stage
 Early 21 12 (57.14%) 9 (42.86%)  
 Late 43 21 (48.84%) 22 (51.16%) 0.532
         
Grade
 1 and 2 20 14 (70.00%) 6 (30.00%)  
 3 29 11 (37.93%) 18 (62.07%) 0.027*
         
Histological subtypes
 Serous+/−papillary 21 13 (61.90%) 8 (38.10%)  
 Others 46 20 (43.48%) 26 (56.52%) 0.162
 Mucinous 14 5 (35.71%) 9 (64.29%)  
 Others 53 28 (52.83%) 25 (47.17%) 0.255
 Endometrioid 17 7 (41.18%) 10 (58.82%)  
 Others 50 26 (52.00%) 24 (48.00%) 0.441
 Clear cells/undifferentiated 15 8 (53.33%) 7 (46.67%)  
 Others 52 25 (48.08%) 27 (51.92%) 0.720
         
Recurrence
 + 31 15 (48.39%) 16 (51.61%)  
 − 31 16 (51.61%) 15 (48.39%) 0.799